FDA Tightens Requirement for COVID-19 Convalescent Plasma Testing and Use
Since the original emergency use authorization was issued in August 2020, new data has prompted this change to convalescent plasma use.
Day: February 8, 2021
COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration
Menu
Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.